Free Trial
→ A weekly dividend fund holding Nvidia and Palantir (From Investors Alley) (Ad)tc pixel Free MEDIF Stock Alerts
OTCMKTS:MEDIF

MediPharm Labs (MEDIF) Stock Price, News & Analysis

MediPharm Labs logo
$0.05 0.00 (-8.02%)
As of 03:51 PM Eastern
Compare

About MediPharm Labs Stock (OTCMKTS:MEDIF)

View Price History Chart DataSkip Price History Chart
Advanced
1 Day 5 Days 30 Days 90 Days 1 Year
Advanced

Key Stats

Today's Range
$0.05
▼
$0.05
50-Day Range
$0.05
▼
$0.06
52-Week Range
$0.04
▼
$0.08
Volume
6,640 shs
Average Volume
73,774 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MediPharm Labs Corp. is a Canadian cannabis company that provides specialized extraction, purification, formulation and contract manufacturing services. The company processes cannabis biomass and produces refined cannabis oils, concentrates and other cannabinoid-based products for medical and adult-use markets.

Its services are designed for licensed cannabis producers, pharmaceutical and consumer packaged-goods companies, and other commercial partners. MediPharm Labs also supports product development, analytical testing, packaging and white-label manufacturing, with an emphasis on pharmaceutical-quality processing and compliance.

Founded in 2015 and headquartered in Barrie, Ontario, MediPharm Labs has served customers in Canada and pursued international opportunities in regulated cannabis and medical markets. Its shares trade under the symbol MEDIF on the OTC Markets.

AI Generated. May Contain Errors.

Receive MEDIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MEDIF Stock News Headlines

MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344409/0/en/medipharm-labs-reports-positive-q2-2026-net-income-and-second-consecutive-quarter-of-positive-adjusted-ebitda.html
MediPharm Labs Sets Date to Report Second Quarter 2026 Financial Results
August 10, 2026  |  financialpost.comF
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
October 6 at 1:00 AM  |  Porter & Company (Ad)
MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer's Disease and Dementia
July 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/14/3326864/0/en/medipharm-labs-announces-positive-phase-ii-libby-trial-results-demonstrating-significant-reduction-in-agitation-associated-with-advanced-alzheimer-s-disease-and-dementia.html
MediPharm Labs Corp MEDIF
July 11, 2026  |  morningstar.comM
MediPharm Labs Stock Price, Quotes and Forecasts | OTC:MEDIF | Benzinga
June 26, 2026  |  benzinga.comhttps://www.benzinga.com/quote/MEDIF
MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders
June 17, 2026  |  financialpost.comF
MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders
June 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/17/3313877/0/en/medipharm-labs-announces-voting-results-from-the-2026-annual-and-special-meeting-of-shareholders.html
See More Headlines

MEDIF Stock Analysis - Frequently Asked Questions

MediPharm Labs' stock was trading at $0.0498 at the beginning of 2026. Since then, MEDIF stock has decreased by 0.8% and is now trading at $0.0494.

Shares of MEDIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:MEDIF
CIK
N/A
Web
www.medipharmlabs.com
Phone
(705) 719-7425
Fax
N/A
Employees
166
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (OTCMKTS:MEDIF) was last updated on 10/6/2026 by MarketBeat.com Staff.
From Our Partners
Nvidia’s record quarter could send this new type of AI soaring
Nvidia just posted 96.2 billion in revenue for a single quarter, more than Coca-Cola generates in an entire ye...
Brownstone Research | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
Do this before December or regret it
Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...
Porter & Company | Sponsoredtc pixel
This list won't be up much longer
Bill Poulos and his team rebuild their Top 10 Stocks to Buy This Quarter report from scratch every quarter, pu...
Profits Run | Sponsoredtc pixel
First Look: Elon’s “Starphone”
Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to...
Stansberry Research | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel